newsletter-givinostat-dmd-approved-hdac-inhibitor-identified-as-top-sma-repurposing-candidate

News post newsletter-givinostat-dmd-approved-hdac-inhibitor-identified-as-top-sma-repurposing-candidate from the SMA Research Platform — cited research evidence, computational findings and platform updates, loaded live from the database. SMA here means 5q spinal muscular atrophy, the SMN1-linked motor neuron disease — not α-SMA (alpha smooth muscle actin, ACTA2).